Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open-label study

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e528-e531. doi: 10.1111/jdv.17201. Epub 2021 Mar 14.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Epidermolysis Bullosa Dystrophica* / genetics
  • Epidermolysis Bullosa*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Skin